Pharma Archives - Page 62 of 76 - Life Sciences Times

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team

August 11, 2025

CGT Global Appoints Dr. Andrew Branagan to Advisory Board to Strengthen Expertise in Cell and Gene Therapy

August 7, 2025

OM1 Expands Neurology Network by 500,000 Patients, Boosting Real-World Evidence Capabilities

August 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

Akamis Bio Appoints C4 Therapeutics CEO Andrew Hirsch to Board of Directors

Study Points to New Mechanism for Schizophrenia Drug Candidate Evenamide

KalVista Drug for Hereditary Angioedema Keeps Orphan Status in EU

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Most Read

ZAP Surgical Marks 5,000th Patient Treated with ZAP-X Gyroscopic Radiosurgery Platform

Bionova Scientific Opens Texas Facility to Expand Plasmid DNA Production for Cell and Gene Therapy Market

Cardiosense Names Dr. John Martin as EVP and Chief Medical Officer Following FDA Clearance of CardioTag Device

OM1 Expands Neurology Network by 500,000 Patients, Boosting Real-World Evidence Capabilities

EDITOR PICKS

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

THIS WEEK'S STORIES

SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team

CGT Global Appoints Dr. Andrew Branagan to Advisory Board to Strengthen Expertise in Cell and Gene Therapy

OM1 Expands Neurology Network by 500,000 Patients, Boosting Real-World Evidence Capabilities

POPULAR CATEGORY

ABOUT US

FOLLOW US